Zealand Pharma A/S

ZLDPF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$1,079-$704-$1,202-$1,018
Dep. & Amort.$26$25$118$40
Deferred Tax$0$0$0-$1
Stock-Based Comp.$87$61$52$54
Change in WC$122$52$10-$166
Other Non-Cash-$87$139$79-$120
Operating Cash Flow-$931-$426-$942-$1,212
Investing Activities
PP&E Inv.-$10-$11-$12-$22
Net Acquisitions$0$0$106$0
Inv. Purchases-$11,458-$2,160-$700$0
Inv. Sales/Matur.$4,138$1,090$887$0
Other Inv. Act.-$3-$13$293$4
Investing Cash Flow-$7,333-$1,094$281-$18
Financing Activities
Debt Repay.$370-$526-$436$648
Stock Issued$8,523$1,564$1,085$775
Stock Repurch.-$352-$42$0-$29
Dividends Paid$0$0$0$0
Other Fin. Act.-$253-$90-$61-$837
Financing Cash Flow$8,288$907$587$1,333
Forex Effect$6-$7$14$66
Net Chg. in Cash$31-$620-$60$169
Supplemental Information
Beg. Cash$449$1,069$1,129$960
End Cash$480$449$1,069$1,129
Free Cash Flow-$944-$449-$954-$1,234
Zealand Pharma A/S (ZLDPF) Financial Statements & Key Stats | AlphaPilot